<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37789266</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>03</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Circulating calprotectin levels four months after severe and non-severe COVID-19.</ArticleTitle><Pagination><StartPage>650</StartPage><MedlinePgn>650</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">650</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-023-08653-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Calprotectin is an inflammatory marker mainly released by activated neutrophils that is increased in acute severe COVID-19. After initial recovery, some patients have persistent respiratory impairment with reduced diffusion capacity of the lungs for carbon monoxide (DLCO) months after infection. Underlying causes of this persistent impairment are unclear. We aimed to investigate the correlation between circulating calprotectin, persistent lung functional impairment and intensive care unit (ICU) stay after COVID-19 in two university hospital centres in Switzerland.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Calprotectin levels were measured in serum from 124 patients (50% male) from the Bern cohort (post-ICU and non-ICU patients) and 68 (76% male) from the Lausanne cohort (only post-ICU patients) four months after COVID-19. Calprotectin was correlated with clinical parameters. Multivariate linear regression (MLR) was performed to evaluate the independent association of calprotectin in different models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall, we found that post-ICU patients, compared to non-ICU, were significantly older (age 59.4&#x2009;&#xb1;&#x2009;13.6 (Bern), 60.5&#x2009;&#xb1;&#x2009;12.0 (Lausanne) vs. 48.8&#x2009;&#xb1;&#x2009;13.4 years) and more obese (BMI 28.6&#x2009;&#xb1;&#x2009;4.5 and 29.1&#x2009;&#xb1;&#x2009;5.3 vs. 25.2&#x2009;&#xb1;&#x2009;6.0&#xa0;kg/m2, respectively). 48% of patients from Lausanne and 44% of the post-ICU Bern cohort had arterial hypertension as a pre-existing comorbidity vs. only 10% in non-ICU patients. Four months after COVID-19 infection, DLCO was lower in post-ICU patients (75.96&#x2009;&#xb1;&#x2009;19.05% predicted Bern, 71.11&#x2009;&#xb1;&#x2009;18.50% Lausanne) compared to non-ICU (97.79&#x2009;&#xb1;&#x2009;21.70% predicted, p&#x2009;&lt;&#x2009;0.01). The post-ICU cohort in Lausanne had similar calprotectin levels when compared to the cohort in Bern (Bern 2.74&#x2009;&#xb1;&#x2009;1.15&#xa0;&#xb5;g/ml, Lausanne 2.49&#x2009;&#xb1;&#x2009;1.13&#xa0;&#xb5;g/ml vs. non-ICU 1.86&#x2009;&#xb1;&#x2009;1.02&#xa0;&#xb5;g/ml; p-value&#x2009;&lt;&#x2009;0.01). Calprotectin correlated negatively with DLCO (r= -0.290, p&#x2009;&lt;&#x2009;0.001) and the forced vital capacity (FVC) (r= -0.311, p&#x2009;&lt;&#x2009;0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Serum calprotectin is elevated in post-ICU patients in two independent cohorts and higher compared to non-ICU patients four months after COVID-19. In addition, there is a negative correlation between calprotectin levels and DLCO or FVC. The relationship between inflammation and lung functional impairment needs further investigations.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">NCT04581135.</AbstractText><CopyrightInformation>&#xa9; 2023. BioMed Central Ltd., part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Abu Hussein</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department for BioMedical Research DBMR, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Machahua</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department for BioMedical Research DBMR, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruchti</LastName><ForeName>S C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horn</LastName><ForeName>M P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Department of Clinical Chemistry, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piquilloud</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Lausanne University Hospital (CHUV), University of Lausanne, Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prella</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Diagnostic Laboratory Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geiser</LastName><ForeName>T K</ForeName><Initials>TK</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department for BioMedical Research DBMR, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>von Garnier</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Diagnostic Laboratory Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Funke-Chambour</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland. manuela.funke-chambour@insel.ch.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department for BioMedical Research DBMR, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. manuela.funke-chambour@insel.ch.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04581135</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D000068397">Clinical Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D039841">Leukocyte L1 Antigen Complex</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006785" MajorTopicYN="N">Hospitals, University</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="Y">Hypertension</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039841" MajorTopicYN="N">Leukocyte L1 Antigen Complex</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ARDS sequelae</Keyword><Keyword MajorTopicYN="N">Calprotectin</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post COVID sequelae</Keyword><Keyword MajorTopicYN="N">Post-infectious inflammation</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>2</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>4</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>3</Day><Hour>23</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37789266</ArticleId><ArticleId IdType="pmc">PMC10546778</ArticleId><ArticleId IdType="doi">10.1186/s12879-023-08653-7</ArticleId><ArticleId IdType="pii">10.1186/s12879-023-08653-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Antonio GE, Wong KT, Hui DSC, Wu A, Lee N, Yuen EHY, et al. Thin-section CT in patients with severe acute respiratory syndrome following hospital discharge: preliminary experience. Radiology. 2003 Sep;228(3):810&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">12805557</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung OY, Chan JWM, Ng CK, Koo CK. The spectrum of pathological changes in severe acute respiratory syndrome (SARS) Histopathology. 2004;45:119&#x2013;24. doi: 10.1111/j.1365-2559.2004.01926.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2559.2004.01926.x</ArticleId><ArticleId IdType="pmc">PMC7194176</ArticleId><ArticleId IdType="pubmed">15279629</ArticleId></ArticleIdList></Reference><Reference><Citation>Ketai L, Paul NS, Wong KTT. Radiology of severe Acute Respiratory Syndrome (SARS): the emerging pathologic-radiologic correlates of an emerging disease. J Thorac Imaging. 2006;21:276&#x2013;83. doi: 10.1097/01.rti.0000213581.14225.f1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.rti.0000213581.14225.f1</ArticleId><ArticleId IdType="pubmed">17110851</ArticleId></ArticleIdList></Reference><Reference><Citation>Das KM, Lee EY, Singh R, Enani MA, al Dossari K, van Gorkom K, et al. Follow-up chest radiographic findings in patients with MERS-CoV after recovery. Indian J Radiol Imaging. 2017;27:342&#x2013;9. doi: 10.4103/ijri.IJRI_469_16.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijri.IJRI_469_16</ArticleId><ArticleId IdType="pmc">PMC5644332</ArticleId><ArticleId IdType="pubmed">29089687</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravaglia C, Doglioni C, Chilosi M, Piciucchi S, Dubini A, Rossi G et al. Clinical, radiological and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection. Eur Respir J; 2022;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8932282</ArticleId><ArticleId IdType="pubmed">35301248</ArticleId></ArticleIdList></Reference><Reference><Citation>Guler SA, Ebner L, Aubry-Beigelman C, Bridevaux PO, Brutsche M, Clarenbach C et al. Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational swiss COVID-19 lung study. Eur Respir J; 2021;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8082329</ArticleId><ArticleId IdType="pubmed">33419891</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenoir A, Christe A, Ebner L, Beigelman-Aubry C, Bridevaux P-O, Brutsche M, et al. Pulmonary recovery 12 months after non-severe and severe COVID-19: the prospective swiss COVID-19 lung study. Respiration. 2023;102:120. doi: 10.1159/000528611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000528611</ArticleId><ArticleId IdType="pmc">PMC9932828</ArticleId><ArticleId IdType="pubmed">36566741</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Liu X, Zhou Y, Yu H, Li R, Zhan Q, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med. 2021;9:747&#x2013;54. doi: 10.1016/S2213-2600(21)00174-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00174-0</ArticleId><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>So M, Kabata H, Fukunaga K, Takagi H, Kuno T. Radiological and functional lung sequelae of COVID-19: a systematic review and meta-analysis. BMC Pulm Med; 2021;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7983097</ArticleId><ArticleId IdType="pubmed">33752639</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open. 2021 May 3;4(5):e2111417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kessel SAM, Olde Hartman TC, Lucassen PLBJ, van Jaarsveld CHM. Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review. Fam Pract. 2022;39:159. doi: 10.1093/fampra/cmab076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmab076</ArticleId><ArticleId IdType="pmc">PMC8414057</ArticleId><ArticleId IdType="pubmed">34268556</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Bluemke DA, L&#xfc;scher TF, Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J. 2022;43:1157&#x2013;72. doi: 10.1093/eurheartj/ehac031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021 Jul 26;374:n1648.</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D, Chalon P, Kohn L, Dauvrin M, Detollenaere J, Maertens de Noordhout C, et al. Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med. 2022;54:1473&#x2013;87. doi: 10.1080/07853890.2022.2076901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ, Halim A, Halim M, Liu S, Aljeldah M, Shammari BR. t al. Inflammatory and vascular biomarkers in post-COVID-19 syndrome: a systematic review and meta-analysis of over 20 biomarkers. Rev Med Virol; 2023;e2424.</Citation><ArticleIdList><ArticleId IdType="pubmed">36708022</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai Y-J, Liu S-H, Manachevakul S, Lee T-A, Kuo C-T, Bello D. Biomarkers in long COVID-19: a systematic review. Front Med (Lausanne). 2023 Jan 20;10:1085988.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9895110</ArticleId><ArticleId IdType="pubmed">36744129</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvin A, Chapuis N, Dunsmore G, Goubet AG, Dubuisson A, Derosa L, et al. Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19. Cell. 2020;182:1401. doi: 10.1016/j.cell.2020.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.002</ArticleId><ArticleId IdType="pmc">PMC7405878</ArticleId><ArticleId IdType="pubmed">32810439</ArticleId></ArticleIdList></Reference><Reference><Citation>Norman GL, Navaz SA, Kanthi Y, Albesa R, Mahler M, Knight JS et al. Circulating calprotectin as a predictive and severity biomarker in patients with COVID-19. Diagnostics (Basel). 2022 May 27;12(6):1324.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9221789</ArticleId><ArticleId IdType="pubmed">35741134</ArticleId></ArticleIdList></Reference><Reference><Citation>Infantino M, Manfredi M, Alessio MG, Previtali G, Grossi V, Benucci M, et al. Clinical utility of circulating calprotectin to assist prediction and monitoring of COVID-19 severity: an italian study. J Med Virol. 2022;94:5758&#x2013;65. doi: 10.1002/jmv.28056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28056</ArticleId><ArticleId IdType="pmc">PMC9538954</ArticleId><ArticleId IdType="pubmed">35941084</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a de Guadiana-Romualdo L, Rodr&#xed;guez Rojas C, Morell-Garc&#xed;a D, Andaluz-Ojeda D, Rodr&#xed;guez Mulero MD, Rodr&#xed;guez-Borja E, et al. Circulating levels of calprotectin, a signature of neutrophil activation in prediction of severe respiratory failure in COVID-19 patients: a multicenter, prospective study (CalCov study) Inflamm Res. 2022;71:57&#x2013;67. doi: 10.1007/s00011-021-01516-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-021-01516-4</ArticleId><ArticleId IdType="pmc">PMC8556860</ArticleId><ArticleId IdType="pubmed">34718856</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardiero G, Palma D, Vano M, Anastasio C, Pinchera B, Ferrandino M et al. Calprotectin levels and neutrophil count are prognostic markers of mortality in COVID-19 patients. Diagnostics (Basel). 2022 Oct 20;12(10):2554.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9601504</ArticleId><ArticleId IdType="pubmed">36292243</ArticleId></ArticleIdList></Reference><Reference><Citation>Pruenster M, Vogl T, Roth J, Sperandio M. S100A8/A9: from basic science to clinical application. Pharmacol Ther Pergamon. 2016;167:120&#x2013;31. doi: 10.1016/j.pharmthera.2016.07.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2016.07.015</ArticleId><ArticleId IdType="pubmed">27492899</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotsiou OS, Papagiannis D, Papadopoulou R, Gourgoulianis KI. Calprotectin in Lung Diseases. Int J Mol Sci. 2021;22:1&#x2013;24. doi: 10.3390/ijms22041706.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22041706</ArticleId><ArticleId IdType="pmc">PMC7915440</ArticleId><ArticleId IdType="pubmed">33567747</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Song R, Wang Z, Jing Z, Wang S, Ma J. S100A8/A9 in inflammation. Front Immunol; 2018;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6004386</ArticleId><ArticleId IdType="pubmed">29942307</ArticleId></ArticleIdList></Reference><Reference><Citation>Machahua C, Guler SA, Horn MP, Planas-Cerezales L, Montes-Worboys A, Geiser TK et al. Serum calprotectin as new biomarker for disease severity in idiopathic pulmonary fibrosis: a cross-sectional study in two independent cohorts. BMJ Open Respir Res. 2021;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7813379</ArticleId><ArticleId IdType="pubmed">33451989</ArticleId></ArticleIdList></Reference><Reference><Citation>Funke-Chambour M, Bridevaux P-O, Clarenbach CF, Soccal PM, Nicod LP, von Garnier C. Swiss recommendations for the Follow-Up and Treatment of Pulmonary Long COVID. Respiration. 2021;100:826&#x2013;41. doi: 10.1159/000517255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000517255</ArticleId><ArticleId IdType="pmc">PMC8339046</ArticleId><ArticleId IdType="pubmed">34091456</ArticleId></ArticleIdList></Reference><Reference><Citation>Anastasio F, Barbuto S, Scarnecchia E, Cosma P, Fugagnoli A, Rossi G et al. Medium-term impact of COVID-19 on pulmonary function, functional capacity and quality of life. Eur Respir J. 2021 Sep 16;58(3):2004015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7877327</ArticleId><ArticleId IdType="pubmed">33574080</ArticleId></ArticleIdList></Reference><Reference><Citation>Krueger T, van den Heuvel J, van Kampen-van den Boogaart V, van Zeeland R, Mehagnoul-Schipper DJ, Barten DG et al. Pulmonary function three to five months after hospital discharge for COVID-19: a single centre cohort study. Sci Rep. 2023 Jan 13;13(1):681.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839688</ArticleId><ArticleId IdType="pubmed">36639404</ArticleId></ArticleIdList></Reference><Reference><Citation>Franquet T, Gim&#xe9;nez A, Ketai L, Mazzini S, Rial A, Pomar V, et al. Air trapping in COVID-19 patients following hospital discharge: retrospective evaluation with paired inspiratory/expiratory thin-section CT. Eur Radiol. 2022;32:4427&#x2013;36. doi: 10.1007/s00330-022-08580-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-022-08580-2</ArticleId><ArticleId IdType="pmc">PMC8884095</ArticleId><ArticleId IdType="pubmed">35226158</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia X, Han X, Cao Y, Fan Y, Yuan M, Li Y et al. Quantitative inspiratory-expiratory chest CT findings in COVID-19 survivors at the 6-month follow-up. Sci Rep. 2022 May 5;12(1):7402.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9070972</ArticleId><ArticleId IdType="pubmed">35513692</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetland G, Fagerhol MK, Dimova-Svetoslavova VP, Mirlashari MR, Nguyen NT, Lind A, et al. Inflammatory markers calprotectin, NETs, syndecan-1 and neopterin in COVID-19 convalescent blood donors. Scand J Clin Lab Invest. 2022;82:481&#x2013;5. doi: 10.1080/00365513.2022.2123387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00365513.2022.2123387</ArticleId><ArticleId IdType="pubmed">36151851</ArticleId></ArticleIdList></Reference><Reference><Citation>Captur G, Moon JC, Topriceanu CC, Joy G, Swadling L, Hallqvist J et al. Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection. EBioMedicine. 2022 Nov;85:104293.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9515404</ArticleId><ArticleId IdType="pubmed">36182629</ArticleId></ArticleIdList></Reference><Reference><Citation>Hua-Huy T, G&#xfc;nther S, Lorut C, Subileau M, Aubourg F, Morbieu C et al. Distal lung inflammation assessed by alveolar concentration of nitric oxide is an individualised biomarker of severe COVID-19 pneumonia. J Pers Med. 2022 Oct 2;12(10):1631</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9605039</ArticleId><ArticleId IdType="pubmed">36294770</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626&#x2013;31. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Koc HC, Xiao J, Liu W, Li Y, Chen G. Long COVID and its management. Int J Biol Sci. 2022;18:4768&#x2013;80. doi: 10.7150/ijbs.75056.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.75056</ArticleId><ArticleId IdType="pmc">PMC9305273</ArticleId><ArticleId IdType="pubmed">35874958</ArticleId></ArticleIdList></Reference><Reference><Citation>Moody R, Sonda S, Johnston FH, Smith KJ, Stephens N, McPherson M et al. Antibodies against spike protein correlate with broad autoantigen recognition 8 months post SARS-CoV-2 exposure, and anti-calprotectin autoantibodies associated with better clinical outcomes. Front Immunol. 2022 Aug 11;13:945021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9403331</ArticleId><ArticleId IdType="pubmed">36032086</ArticleId></ArticleIdList></Reference><Reference><Citation>George PM, Reed A, Desai SR, Devaraj A, Faiez TS, Laverty S et al. A persistent neutrophil-associated immune signature characterizes post-COVID-19 pulmonary sequelae. Sci Transl Med. 2022 Nov 16;14(671):eabo5795.</Citation><ArticleIdList><ArticleId IdType="pubmed">36383686</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>